JPH0566388B2 - - Google Patents

Info

Publication number
JPH0566388B2
JPH0566388B2 JP60008576A JP857685A JPH0566388B2 JP H0566388 B2 JPH0566388 B2 JP H0566388B2 JP 60008576 A JP60008576 A JP 60008576A JP 857685 A JP857685 A JP 857685A JP H0566388 B2 JPH0566388 B2 JP H0566388B2
Authority
JP
Japan
Prior art keywords
sup
formula
integer
pharmaceutically acceptable
hydrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP60008576A
Other languages
English (en)
Japanese (ja)
Other versions
JPS60163872A (ja
Inventor
Monkobitsuku Aibo
Aaru Kurensho Ronii
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of JPS60163872A publication Critical patent/JPS60163872A/ja
Publication of JPH0566388B2 publication Critical patent/JPH0566388B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/08—1,2,5-Oxadiazoles; Hydrogenated 1,2,5-oxadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
JP60008576A 1984-01-23 1985-01-22 ヒスタミンｈ↓２‐受体拮抗活性をもつ３，４‐２置換‐１，２，５‐オキサジアゾール Granted JPS60163872A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US573258 1984-01-23
US06/573,258 US4507485A (en) 1984-01-23 1984-01-23 3,4-Disubstituted-1,2,5-oxadiazoles having histamine H2 -receptor antagonist activity

Publications (2)

Publication Number Publication Date
JPS60163872A JPS60163872A (ja) 1985-08-26
JPH0566388B2 true JPH0566388B2 (enExample) 1993-09-21

Family

ID=24291260

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60008576A Granted JPS60163872A (ja) 1984-01-23 1985-01-22 ヒスタミンｈ↓２‐受体拮抗活性をもつ３，４‐２置換‐１，２，５‐オキサジアゾール

Country Status (5)

Country Link
US (1) US4507485A (enExample)
EP (1) EP0150073B1 (enExample)
JP (1) JPS60163872A (enExample)
AT (1) ATE56962T1 (enExample)
DE (1) DE3579827D1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2212409C1 (ru) * 2001-12-24 2003-09-20 Биологический факультет Московского государственного университета им. М.В. Ломоносова Производные 1,4,2,5-диоксадиазина
RS52711B (sr) 2005-05-10 2013-08-30 Incyte Corporation Modulatori indolamin 2,3-dioksigenaze i postupci upotrebe istih
PL2315756T3 (pl) 2008-07-08 2015-02-27 Incyte Holdings Corp 1,2,5-oksadiazole jako inhibitory 2,3-dioksygenazy indoloaminy
KR102617531B1 (ko) 2013-11-08 2023-12-27 인사이트 홀딩스 코포레이션 인돌아민 2,3-디옥시게나제 억제제의 합성 방법
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH479605A (de) * 1967-02-07 1969-10-15 Geigy Ag J R Verfahren zur Herstellung von neuen Furazanderivaten
CH496721A (de) * 1968-02-01 1970-09-30 Geigy Ag J R Verfahren zur Herstellung von neuen Furoxanderivaten
DE2804576A1 (de) * 1977-02-15 1978-08-17 Lafon Labor Phenylamidin-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
CA1138474A (en) * 1978-03-08 1982-12-28 Riekert Kok Process for the preparation of a 1,2-dioxime
DE3012862A1 (de) * 1980-04-02 1981-10-08 Cassella Ag, 6000 Frankfurt Substituierte 1,2,5-oxdiazol-2-oxide als pharmazeutische wirkstoffe, ihre verwendung und sie enthaltende arzneimittel
DE3047730A1 (de) * 1980-12-18 1982-07-15 Cassella Ag, 6000 Frankfurt 3,4-bis-substituierte 1,2,5-oxdiazol-2-oxide, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende pharmazeutische zubereitungen
DE3047749A1 (de) * 1980-12-18 1982-07-22 Cassella Ag, 6000 Frankfurt 3,4-disubstituierte 1,2,5-oxdiazol-2-oxide, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende pharmazeutische zubereitungen

Also Published As

Publication number Publication date
EP0150073B1 (en) 1990-09-26
US4507485A (en) 1985-03-26
JPS60163872A (ja) 1985-08-26
DE3579827D1 (de) 1990-10-31
ATE56962T1 (de) 1990-10-15
EP0150073A1 (en) 1985-07-31

Similar Documents

Publication Publication Date Title
SU1375127A3 (ru) Способ получени производных 1,2-диаминоциклобутен-3,4-диона или их хлоргидратов
EP0482939A1 (en) Isoquinolinone derivative
JP2005518357A (ja) ベータ３アドレナリンアゴニスト
HU188852B (en) Process for producing thiazolidine derivatives active against gastric ulcer and intestinal ulcer
JP2001525399A (ja) 選択的β３アドレナリン作動性作動薬
US6903132B2 (en) Non-peptide GnRH agents, pharmaceutical compositions and methods for their use
JPS62145049A (ja) アミノスチリル化合物及びそれを有効成分とするロイコトリエンきつ抗剤
WO2012051502A1 (en) Methods and compositions related to neuroactive thiazoline compounds
US4522943A (en) Chemical compounds
JPH0566388B2 (enExample)
PT87148B (pt) Processo para a preparacao de novas aminas triciclicas derivadas do 5,6,7,8-tetrahidro-nafto-{2,3b} 2,3-dihidro-furano e do 6,7,8,9-tetrahidro-5h-benzociclohepta {2,3b} 2,3-dihidro-furano
US4526973A (en) Chemical compounds
JPH0530814B2 (enExample)
SK278141B6 (en) Enolether amide 1,1-dioxo-6-chloro-4-hydroxy-2-methyl-n- -(2-pyridyl)-2h-thieno(2,3-e)1,2-thiazine-3-carboxylic acid, method of its production and pharmaceutical agent
US4546188A (en) Substituted 1,2-diaminocyclobutene-3,4-diones
JPH06135925A (ja) ヒスタミンｈ▲２▼−受容体拮抗活性をもつ置換３，４−ジアミノ−１，２，５−チアジアゾール用中間体
US4772704A (en) 2,5-disubstituted-4(3H)-pyrimidones having histamine H2 -receptor antagonist activity
KR20010072408A (ko) Ｎ-치환 아자비시클로헵탄 유도체, 그의 제조 및 용도
JPH06510773A (ja) チアジアゾロ〔４，３−ａ〕ピリジン誘導体、それらの製造方法およびこれらを含む薬剤
US4788184A (en) Substituted 3-cyclobutene-1,2-diones as anti-ulcer agents
US4607105A (en) 3-cyclobutene-1,2-dione intermediates
JPH0262554B2 (enExample)
JPH0351711B2 (enExample)
NZ205891A (en) 4-hydroxy-2h-1,2-benzothiazine-3-carboxamide 1,1-dioxides and pharmaceutical compositions
JPH0544470B2 (enExample)